Skip to main content
OpenTrials
Completed

NCT Number: NCT00000197

Propranolol for Treatment of Cocaine Addiction - 2

The purpose of this study is to evaluate the safety and efficacy of propanolol in the early treatment of cocaine dependence.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cocaine-Related Disorders Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

25 year–49 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University of Pennsylvania

Philadelphia, Pennsylvania, 19104 6178, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Please contact site for information.

Treatment and study plan

Propranolol

Drug

Primary outcomes

  1. Side effects

  2. Cocaine use

  3. Cocaine withdrawal

  4. Cocaine craving

  5. Mood and anxiety

  6. Clinical improvement

Sponsors and collaborators

Lead sponsor

National Institute on Drug Abuse (NIDA)

Nih

Collaborators

  • University of Pennsylvania

Registry information

Official study title

Propranolol for Treatment of Cocaine Addiction

Important dates

Study start
1987
Primary completion
2002
Study completion
2002
First posted
Sep 21, 1999
Registry last updated
Jan 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.